EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RAD50 missense variants differentially affect the DNA damage response and mitotic progression

Hanna Redeker, Swantje Kebel, Lea Völkening, Anna Vatselia, Louisa Weinhold, Girmay Asgedom, Axel Schambach, Detlev Schindler, Thilo Dörk iD, Kristine Bousset iD

FEBS Letters · 2025

DOI: 10.1002/1873-3468.70175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, 2025. Verfasst von Hanna Redeker und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gynaecology Research Unit, Hannover Medical School, Germany. Hauptthemen laut MEDLINE: Mitosis, Mutation, Missense, DNA Damage, DNA-Binding Proteins. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Claudia von Schilling Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RAD50 is the central protein of the MRN complex and crucial in DNA double‐strand break repair. RAD50 deficiency causes a genomic instability disorder characterized by microcephaly and stunted growth. Using lentiviral constructs, we investigated whether cancer‐related RAD50 missense variants can complement the delayed damage response after exposure to the chemotherapeutic agent epirubicin and/or mitotic progression in RAD50‐deficient fibroblasts. Eight missense variants, all capable of forming an MRN complex, supported the DNA damage response and mitotic features to different extents, indicating these functions are separable. Three variants showed both an impaired epirubicin response and slowed cell division in the likely pathogenic range. Assessing RAD50 missense variants with distinct functional readouts may help to further elucidate their differential roles in immunodeficiency and cancer and could improve therapeutic strategies. Impact statement RAD50 has a strong impact on DNA repair and cancer therapy. Here, we analyse RAD50 missense variants at four functional levels. Some variants showed an impaired epirubicin response and mitotic progression in the pathological range, while for others these endpoints were separable. Functional heterogeneity of RAD50 variants could contribute to clinical variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitosisMutation, MissenseDNA DamageDNA-Binding ProteinsDNA Repair EnzymesHumansDNA RepairEpirubicinDNA Breaks, Double-StrandedFibroblastsAcid Anhydride Hydrolases

Stichwörter der Autor:innen

DNA damage responseMRN complexRAD50 deficiencybreast cancerepirubicinmissense variantsseparation of function

Substanzen

RAD50 protein, humanDNA-Binding ProteinsEpirubicinDNA Repair EnzymesAcid Anhydride Hydrolases

Autor:innen und Institutionen

  • Gynaecology Research Unit, Hannover Medical School, Germany.
  • Institute of Experimental Hematology, Hannover Medical School, Germany.
  • Institute of Human Genetics, Biocenter, University Würzburg, Germany.

ORCID-Profile: Thilo Dörk, Kristine Bousset

Förderung

  • Claudia von Schilling Foundation

Zitieren

APA

Redeker, H., Kebel, S., Völkening, L., Vatselia, A., Weinhold, L., Asgedom, G., Schambach, A., Schindler, D., Dörk, T., & Bousset, K. (2025). RAD50 missense variants differentially affect the DNA damage response and mitotic progression. FEBS Letters. https://doi.org/10.1002/1873-3468.70175

Vancouver

Redeker H, Kebel S, Völkening L, Vatselia A, Weinhold L, Asgedom G, et al. RAD50 missense variants differentially affect the DNA damage response and mitotic progression. FEBS Letters. 2025. doi:10.1002/1873-3468.70175

BibTeX
@article{Redeker2025,
  author = {Redeker, Hanna and Kebel, Swantje and Völkening, Lea and Vatselia, Anna and Weinhold, Louisa and Asgedom, Girmay and Schambach, Axel and Schindler, Detlev and Dörk, Thilo and Bousset, Kristine},
  title = {RAD50 missense variants differentially affect the DNA damage response and mitotic progression},
  journal = {FEBS Letters},
  year = {2025},
  doi = {10.1002/1873-3468.70175}
}
Kostenlos starten →